SCOPUS 정보 검색 플랫폼

Volumn 211, Issue 11, 2014, Pages 2213-2230

Myeloproliferative neoplasms can be initiated from a single hematopoietic stem cell expressing JAK2-V617F

(9) Lundberg, Pontus a Takizawa, Hitoshi b Kubovcakova, Lucia a Guo, Guoji c Hao Shen, Hui a Dirnhofer, Stephan d Orkin, Stuart H c Manz, Markus G b Skoda, Radek C a

a UNIVERSITY HOSPITAL BASEL (Switzerland)

b UNIVERSITY HOSPITAL ZURICH (Switzerland)

c BOSTON CHILDREN S HOSPITAL (United States)

d UNIVERSITY HOSPITAL BASEL (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; JANUS KINASE 2; BIOLOGICAL MARKER; LY ANTIGEN; LY6A PROTEIN, MOUSE; MEMBRANE ANTIGEN; MEMBRANE PROTEIN; STEM CELL FACTOR RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DIVISION; CELL TRANSPLANTATION; CONTROLLED STUDY; DILUTION; DNA DAMAGE; ERYTHROCYTOSIS; GENE EXPRESSION; GENETIC ANALYSIS; HEMATOPOIETIC STEM CELL; MOUSE; MYELOPROLIFERATIVE NEOPLASM; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; RECIPIENT; SINGLE CELL ANALYSIS; THROMBOCYTOSIS; ALLELE; ANIMAL; BONE MARROW TRANSPLANTATION; CELL CYCLE; CELL LINEAGE; CELL TRANSFORMATION; CLUSTER ANALYSIS; FEMALE; GENE EXPRESSION PROFILING; GENETICS; HISTOCOMPATIBILITY; IMMUNOPHENOTYPING; KNOCKOUT MOUSE; METABOLISM; MUTATION; MYELOPROLIFERATIVE DISORDER; PATHOLOGY;

ALLELES; ANIMALS; ANTIGENS, LY; ANTIGENS, SURFACE; BIOLOGICAL MARKERS; BONE MARROW TRANSPLANTATION; CELL CYCLE; CELL LINEAGE; CELL TRANSFORMATION, NEOPLASTIC; CLUSTER ANALYSIS; DNA DAMAGE; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HEMATOPOIETIC STEM CELLS; IMMUNOPHENOTYPING; JANUS KINASE 2; MEMBRANE PROTEINS; MICE; MICE, KNOCKOUT; MUTATION; MYELOPROLIFERATIVE DISORDERS; PHENOTYPE; PROTO-ONCOGENE PROTEINS C-KIT; TRANSPLANTATION CHIMERA;

EID: 84908258893 PISSN: 00221007 EISSN: 15409538 Source Type: Journal
DOI: 10.1084/jem.20131371 Document Type: Article

Times cited : (88)

References (63)

1
- 79960248721
- DNMT3A mutational analysis in primary myelofibrosis, chronic myelomonocytic leukemia and advanced phases of myeloproliferative neoplasms
- Abdel-Wahab, O., A. Pardanani, R. Rampal, T.L. Lasho, R.L. Levine, and A. Tefferi. 2011. DNMT3A mutational analysis in primary myelofibrosis, chronic myelomonocytic leukemia and advanced phases of myeloproliferative neoplasms. Leukemia. 25:1219-1220. http://dx.doi.org/10.1038/ leu.2011.82
- (2011) Leukemia. , vol.25 , pp. 1219-1220
- Abdel-Wahab, O.¹ Pardanani, A.² Rampal, R.³ Lasho, T.L.⁴ Levine, R.L.⁵ Tefferi, A.⁶

2
- 77951759127
- Conditional expression of heterozygous or homozygous Jak2V617F from its endogenous promoter induces a polycythemia vera-like disease
- Akada, H., D. Yan, H. Zou, S. Fiering, R.E. Hutchison, and M.G. Mohi. 2010. Conditional expression of heterozygous or homozygous Jak2V617F from its endogenous promoter induces a polycythemia vera-like disease. Blood. 115:3589-3597. http://dx.doi.org/10.1182/blood-2009-04-215848
- (2010) Blood. , vol.115 , pp. 3589-3597
- Akada, H.¹ Yan, D.² Zou, H.³ Fiering, S.⁴ Hutchison, R.E.⁵ Mohi, M.G.⁶

3
- 20144363192
- Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders
- Baxter, E.J., L.M. Scott, P.J. Campbell, C. East, N. Fourouclas, S. Swanton, G.S. Vassiliou, A.J. Bench, E.M. Boyd, N. Curtin, et al. Cancer Genome Project. 2005. Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. Lancet. 365:1054-1061. http://dx.doi.org/10 .1016/S0140-6736(05)71142-9
- (2005) Lancet. , vol.365 , pp. 1054-1061
- Baxter, E.J.¹ Scott, L.M.² Campbell, P.J.³ East, C.⁴ Fourouclas, N.⁵ Swanton, S.⁶ Vassiliou, G.S.⁷ Bench, A.J.⁸ Boyd, E.M.⁹ Curtin, N.¹⁰

4
- 60649096136
- Clonal diversity in the myeloproliferative neoplasms: independent origins of genetically distinct clones
- Beer, P.A., A.V. Jones, A.J. Bench, A. Goday-Fernandez, E.M. Boyd, K.J. Vaghela, W.N. Erber, B. Odeh, C. Wright, M.F. McMullin, et al. 2009. Clonal diversity in the myeloproliferative neoplasms: independent origins of genetically distinct clones. Br. J. Haematol. 144:904-908. http://dx .doi.org/10.1111/j.1365-2141.2008.07560.x
- (2009) Br. J. Haematol. , vol.144 , pp. 904-908
- Beer, P.A.¹ Jones, A.V.² Bench, A.J.³ Goday-Fernandez, A.⁴ Boyd, E.M.⁵ Vaghela, K.J.⁶ Erber, W.N.⁷ Odeh, B.⁸ Wright, C.⁹ McMullin, M.F.¹⁰

5
- 84857873445
- Hematopoietic stem cell subtypes expand differentially during development and display distinct lymphopoietic programs
- Benz, C., M.R. Copley, D.G. Kent, S. Wohrer, A. Cortes, N. Aghaeepour, E. Ma, H. Mader, K. Rowe, C. Day, et al. 2012. Hematopoietic stem cell subtypes expand differentially during development and display distinct lymphopoietic programs. Cell Stem Cell. 10:273-283. http://dx.doi.org/ 10.1016/j.stem.2012.02.007
- (2012) Cell Stem Cell. , vol.10 , pp. 273-283
- Benz, C.¹ Copley, M.R.² Kent, D.G.³ Wohrer, S.⁴ Cortes, A.⁵ Aghaeepour, N.⁶ Ma, E.⁷ Mader, H.⁸ Rowe, K.⁹ Day, C.¹⁰

6
- 70450239681
- Mutations of ASXL1 gene in myeloproliferative neoplasms
- Carbuccia, N., A. Murati, V. Trouplin, M. Brecqueville, J. Adélaïde, J. Rey, W. Vainchenker, O.A. Bernard, M. Chaffanet, N. Vey, et al. 2009. Mutations of ASXL1 gene in myeloproliferative neoplasms. Leukemia. 23:2183- 2186. http://dx.doi.org/10.1038/leu.2009.141
- (2009) Leukemia. , vol.23 , pp. 2183- 2186
- Carbuccia, N.¹ Murati, A.² Trouplin, V.³ Brecqueville, M.⁴ Adélaïde, J.⁵ Rey, J.⁶ Vainchenker, W.⁷ Bernard, O.A.⁸ Chaffanet, M.⁹ Vey, N.¹⁰

7
- 78249256979
- Distinct clinical phenotypes associated with JAK2V617F reflect differential STAT1 signaling
- Chen, E., P.A. Beer, A.L. Godfrey, C.A. Ortmann, J. Li, A.P. Costa-Pereira, C.E. Ingle, E.T. Dermitzakis, P.J. Campbell, and A.R. Green. 2010. Distinct clinical phenotypes associated with JAK2V617F reflect differential STAT1 signaling. Cancer Cell. 18:524-535. http://dx.doi.org/10 .1016/j.ccr.2010.10.013
- (2010) Cancer Cell. , vol.18 , pp. 524-535
- Chen, E.¹ Beer, P.A.² Godfrey, A.L.³ Ortmann, C.A.⁴ Li, J.⁵ Costa-Pereira, A.P.⁶ Ingle, C.E.⁷ Dermitzakis, E.T.⁸ Campbell, P.J.⁹ Green, A.R.¹⁰

8
- 84866124810
- FLT3-ITD knockin impairs hematopoietic stem cell quiescence/homeostasis, leading to myeloproliferative neoplasm
- Chu, S.H., D. Heiser, L. Li, I. Kaplan, M. Collector, D. Huso, S.J. Sharkis, C. Civin, and D. Small. 2012. FLT3-ITD knockin impairs hematopoietic stem cell quiescence/homeostasis, leading to myeloproliferative neoplasm. Cell Stem Cell. 11:346-358. http://dx.doi.org/10.1016/j.stem.2012.05.027
- (2012) Cell Stem Cell. , vol.11 , pp. 346-358
- Chu, S.H.¹ Heiser, D.² Li, L.³ Kaplan, I.⁴ Collector, M.⁵ Huso, D.⁶ Sharkis, S.J.⁷ Civin, C.⁸ Small, D.⁹

9
- 36448992228
- Efficient transplantation via antibody-based clearance of hematopoietic stem cell niches
- Czechowicz, A., D. Kraft, I.L. Weissman, and D. Bhattacharya. 2007. Efficient transplantation via antibody-based clearance of hematopoietic stem cell niches. Science. 318:1296-1299. http://dx.doi.org/10.1126/science .1149726
- (2007) Science. , vol.318 , pp. 1296-1299
- Czechowicz, A.¹ Kraft, D.² Weissman, I.L.³ Bhattacharya, D.⁴

10
- 66249137734
- Mutation in TET2 in myeloid cancers
- Delhommeau, F., S. Dupont, V. Della Valle, C. James, S. Trannoy, A. Massé, O. Kosmider, J.P. Le Couedic, F. Robert, A. Alberdi, et al. 2009. Mutation in TET2 in myeloid cancers. N. Engl. J. Med. 360:2289-2301. http:// dx.doi.org/10.1056/NEJMoa0810069
- (2009) N. Engl. J. Med. , vol.360 , pp. 2289-2301
- Delhommeau, F.¹ Dupont, S.² Della Valle, V.³ James, C.⁴ Trannoy, S.⁵ Massé, A.⁶ Kosmider, O.⁷ Le Couedic, J.P.⁸ Robert, F.⁹ Alberdi, A.¹⁰

11
- 34547692981
- Long-term propagation of distinct hematopoietic differentiation programs in vivo
- Dykstra, B., D. Kent, M. Bowie, L. McCaffrey, M. Hamilton, K. Lyons, S.J. Lee, R. Brinkman, and C. Eaves. 2007. Long-term propagation of distinct hematopoietic differentiation programs in vivo. Cell Stem Cell. 1:218-229. http://dx.doi.org/10.1016/j.stem.2007.05.015
- (2007) Cell Stem Cell. , vol.1 , pp. 218-229
- Dykstra, B.¹ Kent, D.² Bowie, M.³ McCaffrey, L.⁴ Hamilton, M.⁵ Lyons, K.⁶ Lee, S.J.⁷ Brinkman, R.⁸ Eaves, C.⁹

12
- 77955085750
- Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders
- Ernst, T., A.J. Chase, J. Score, C.E. Hidalgo-Curtis, C. Bryant, A.V. Jones, K. Waghorn, K. Zoi, F.M. Ross, A. Reiter, et al. 2010. Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders. Nat. Genet. 42:722-726. http://dx.doi.org/10.1038/ng.621
- (2010) Nat. Genet. , vol.42 , pp. 722-726
- Ernst, T.¹ Chase, A.J.² Score, J.³ Hidalgo-Curtis, C.E.⁴ Bryant, C.⁵ Jones, A.V.⁶ Waghorn, K.⁷ Zoi, K.⁸ Ross, F.M.⁹ Reiter, A.¹⁰

13
- 84880790360
- CD41 expression marks myeloid-biased adult hematopoietic stem cells and increases with age
- Gekas, C., and T. Graf. 2013. CD41 expression marks myeloid-biased adult hematopoietic stem cells and increases with age. Blood. 121:4463-4472. http://dx.doi.org/10.1182/blood-2012-09-457929
- (2013) Blood. , vol.121 , pp. 4463-4472
- Gekas, C.¹ Graf, T.²

14
- 84885172419
- Mapping cellular hierarchy by singlecell analysis of the cell surface repertoire
- Guo, G., S. Luc, E. Marco, T.W. Lin, C. Peng, M.A. Kerenyi, S. Beyaz, W. Kim, J. Xu, P.P. Das, et al. 2013. Mapping cellular hierarchy by singlecell analysis of the cell surface repertoire. Cell Stem Cell. 13:492-505. http://dx.doi.org/10.1016/j.stem.2013.07.017
- (2013) Cell Stem Cell. , vol.13 , pp. 492-505
- Guo, G.¹ Luc, S.² Marco, E.³ Lin, T.W.⁴ Peng, C.⁵ Kerenyi, M.A.⁶ Beyaz, S.⁷ Kim, W.⁸ Xu, J.⁹ Das, P.P.¹⁰

15
- 84886850069
- JAK2V617F expression in mice amplifies early hematopoietic cells and gives them a competitive advantage that is hampered by IFNα
- Hasan, S., C. Lacout, C. Marty, M. Cuingnet, E. Solary, W. Vainchenker, and J.L. Villeval. 2013. JAK2V617F expression in mice amplifies early hematopoietic cells and gives them a competitive advantage that is hampered by IFNα. Blood. 122:1464-1477. http://dx.doi.org/10.1182/blood-2013-04-498956
- (2013) Blood. , vol.122 , pp. 1464-1477
- Hasan, S.¹ Lacout, C.² Marty, C.³ Cuingnet, M.⁴ Solary, E.⁵ Vainchenker, W.⁶ Villeval, J.L.⁷

16
- 17844383458
- A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera
- James, C., V. Ugo, J.P. Le Couédic, J. Staerk, F. Delhommeau, C. Lacout, L. Garçon, H. Raslova, R. Berger, A. Bennaceur-Griscelli, et al. 2005. A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera. Nature. 434:1144-1148. http://dx.doi.org/10.1038/ nature03546
- (2005) Nature. , vol.434 , pp. 1144-1148
- James, C.¹ Ugo, V.² Le Couédic, J.P.³ Staerk, J.⁴ Delhommeau, F.⁵ Lacout, C.⁶ Garçon, L.⁷ Raslova, H.⁸ Berger, R.⁹ Bennaceur-Griscelli, A.¹⁰

17
- 63449099560
- JAK2 haplotype is a major risk factor for the development of myeloproliferative neoplasms
- Jones, A.V., A. Chase, R.T. Silver, D. Oscier, K. Zoi, Y.L. Wang, H. Cario, H.L. Pahl, A. Collins, A. Reiter, et al. 2009. JAK2 haplotype is a major risk factor for the development of myeloproliferative neoplasms. Nat. Genet. 41:446-449. http://dx.doi.org/10.1038/ng.334
- (2009) Nat. Genet. , vol.41 , pp. 446-449
- Jones, A.V.¹ Chase, A.² Silver, R.T.³ Oscier, D.⁴ Zoi, K.⁵ Wang, Y.L.⁶ Cario, H.⁷ Pahl, H.L.⁸ Collins, A.⁹ Reiter, A.¹⁰

18
- 84879396181
- Selfrenewal of single mouse hematopoietic stem cells is reduced by JAK2V617F without compromising progenitor cell expansion
- Kent, D.G., J. Li, H. Tanna, J. Fink, K. Kirschner, D.C. Pask, Y. Silber, T.L. Hamilton, R. Sneade, B.D. Simons, and A.R. Green. 2013. Selfrenewal of single mouse hematopoietic stem cells is reduced by JAK2V617F without compromising progenitor cell expansion. PLoS Biol. 11:e1001576. http://dx.doi.org/10.1371/journal.pbio.1001576
- (2013) PLoS Biol. , vol.11 , pp. e1001576
- Kent, D.G.¹ Li, J.² Tanna, H.³ Fink, J.⁴ Kirschner, K.⁵ Pask, D.C.⁶ Silber, Y.⁷ Hamilton, T.L.⁸ Sneade, R.⁹ Simons, B.D.¹⁰ Green, A.R.¹¹

19
- 21244463426
- SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells
- Kiel, M.J., O.H. Yilmaz, T. Iwashita, O.H. Yilmaz, C. Terhorst, and S.J. Morrison. 2005. SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells. Cell. 121:1109-1121. http://dx.doi.org/10.1016/j.cell.2005.05.026
- (2005) Cell. , vol.121 , pp. 1109-1121
- Kiel, M.J.¹ Yilmaz, O.H.² Iwashita, T.³ Yilmaz, O.H.⁴ Terhorst, C.⁵ Morrison, S.J.⁶

20
- 84871182464
- Anti-CD47 antibodies promote phagocytosis and inhibit the growth of human myeloma cells
- Kim, D., J. Wang, S.B. Willingham, R. Martin, G. Wernig, and I.L. Weissman. 2012. Anti-CD47 antibodies promote phagocytosis and inhibit the growth of human myeloma cells. Leukemia. 26:2538-2545. http://dx.doi.org/10.1038/leu.2012.141
- (2012) Leukemia. , vol.26 , pp. 2538-2545
- Kim, D.¹ Wang, J.² Willingham, S.B.³ Martin, R.⁴ Wernig, G.⁵ Weissman, I.L.⁶

21
- 84890372480
- Somatic mutations of calreticulin in myeloproliferative neoplasms
- Klampfl, T., H. Gisslinger, A.S. Harutyunyan, H. Nivarthi, E. Rumi, J.D. Milosevic, N.C. Them, T. Berg, B. Gisslinger, D. Pietra, et al. 2013. Somatic mutations of calreticulin in myeloproliferative neoplasms. N. Engl. J. Med. 369:2379-2390. http://dx.doi.org/10.1056/NEJMoa1311347
- (2013) N. Engl. J. Med. , vol.369 , pp. 2379-2390
- Klampfl, T.¹ Gisslinger, H.² Harutyunyan, A.S.³ Nivarthi, H.⁴ Rumi, E.⁵ Milosevic, J.D.⁶ Them, N.C.⁷ Berg, T.⁸ Gisslinger, B.⁹ Pietra, D.¹⁰

22
- 17644424955
- A gain-of-function mutation of JAK2 in myeloproliferative disorders
- Kralovics, R., F. Passamonti, A.S. Buser, S.S. Teo, R. Tiedt, J.R. Passweg, A. Tichelli, M. Cazzola, and R.C. Skoda. 2005. A gain-of-function mutation of JAK2 in myeloproliferative disorders. N. Engl. J. Med. 352:1779-1790. http://dx.doi.org/10.1056/NEJMoa051113
- (2005) N. Engl. J. Med. , vol.352 , pp. 1779-1790
- Kralovics, R.¹ Passamonti, F.² Buser, A.S.³ Teo, S.S.⁴ Tiedt, R.⁵ Passweg, J.R.⁶ Tichelli, A.⁷ Cazzola, M.⁸ Skoda, R.C.⁹

23
- 33747199312
- Acquisition of the V617F mutation of JAK2 is a late genetic event in a subset of patients with myeloproliferative disorders
- Kralovics, R., S.S. Teo, S. Li, A. Theocharides, A.S. Buser, A. Tichelli, and R.C. Skoda. 2006. Acquisition of the V617F mutation of JAK2 is a late genetic event in a subset of patients with myeloproliferative disorders. Blood. 108:1377-1380. http://dx.doi.org/10.1182/blood- 2005-11-009605
- (2006) Blood. , vol.108 , pp. 1377-1380
- Kralovics, R.¹ Teo, S.S.² Li, S.³ Theocharides, A.⁴ Buser, A.S.⁵ Tichelli, A.⁶ Skoda, R.C.⁷

24
- 84880507665
- Mutational heterogeneity in cancer and the search for new cancer-associated genes
- Lawrence, M.S., P. Stojanov, P. Polak, G.V. Kryukov, K. Cibulskis, A. Sivachenko, S.L. Carter, C. Stewart, C.H. Mermel, S.A. Roberts, et al. 2013. Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature. 499:214-218. http://dx.doi.org/10.1038/nature12213
- (2013) Nature. , vol.499 , pp. 214-218
- Lawrence, M.S.¹ Stojanov, P.² Polak, P.³ Kryukov, G.V.⁴ Cibulskis, K.⁵ Sivachenko, A.⁶ Carter, S.L.⁷ Stewart, C.⁸ Mermel, C.H.⁹ Roberts, S.A.¹⁰

25
- 20244369569
- Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis
- Levine, R.L., M. Wadleigh, J. Cools, B.L. Ebert, G. Wernig, B.J. Huntly, T.J. Boggon, I. Wlodarska, J.J. Clark, S. Moore, et al. 2005. Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis. Cancer Cell. 7:387-397. http://dx.doi.org/10.1016/j.ccr.2005.03.023
- (2005) Cancer Cell. , vol.7 , pp. 387-397
- Levine, R.L.¹ Wadleigh, M.² Cools, J.³ Ebert, B.L.⁴ Wernig, G.⁵ Huntly, B.J.⁶ Boggon, T.J.⁷ Wlodarska, I.⁸ Clark, J.J.⁹ Moore, S.¹⁰

26
- 0032726951
- Leukaemia disease genes: large-scale cloning and pathway predictions
- Li, J., H. Shen, K.L. Himmel, A.J. Dupuy, D.A. Largaespada, T. Nakamura, J.D. Shaughnessy Jr., N.A. Jenkins, and N.G. Copeland. 1999. Leukaemia disease genes: large-scale cloning and pathway predictions. Nat. Genet. 23:348-353. http://dx.doi.org/10.1038/15531
- (1999) Nat. Genet. , vol.23 , pp. 348-353
- Li, J.¹ Shen, H.² Himmel, K.L.³ Dupuy, A.J.⁴ Largaespada, D.A.⁵ Nakamura, T.⁶ Shaughnessy, J.D.⁷ Jenkins, N.A.⁸ Copeland, N.G.⁹

27
- 77956578342
- JAK2 V617F impairs hematopoietic stem cell function in a conditional knock-in mouse model of JAK2 V617F-positive essential thrombocythemia
- Li, J., D. Spensberger, J.S. Ahn, S. Anand, P.A. Beer, C. Ghevaert, E. Chen, A. Forrai, L.M. Scott, R. Ferreira, et al. 2010. JAK2 V617F impairs hematopoietic stem cell function in a conditional knock-in mouse model of JAK2 V617F-positive essential thrombocythemia. Blood. 116:1528- 1538. http://dx.doi.org/10.1182/blood-2009-12-259747
- (2010) Blood. , vol.116 , pp. 1528- 1538
- Li, J.¹ Spensberger, D.² Ahn, J.S.³ Anand, S.⁴ Beer, P.A.⁵ Ghevaert, C.⁶ Chen, E.⁷ Forrai, A.⁸ Scott, L.M.⁹ Ferreira, R.¹⁰

28
- 79956096380
- Mouse models of myeloproliferative neoplasms: JAK of all grades
- Li, J., D.G. Kent, E. Chen, and A.R. Green. 2011. Mouse models of myeloproliferative neoplasms: JAK of all grades. Dis. Model. Mech. 4:311-317. http://dx.doi.org/10.1242/dmm.006817
- (2011) Dis. Model. Mech. , vol.4 , pp. 311-317
- Li, J.¹ Kent, D.G.² Chen, E.³ Green, A.R.⁴

29
- 84889598519
- Oncogenic Nras has bimodal effects on stem cells that sustainably increase competitiveness
- Li, Q., N. Bohin, T. Wen, V. Ng, J. Magee, S.C. Chen, K. Shannon, and S.J. Morrison. 2013. Oncogenic Nras has bimodal effects on stem cells that sustainably increase competitiveness. Nature. 504:143-147. http:// dx.doi.org/10.1038/nature12830
- (2013) Nature. , vol.504 , pp. 143-147
- Li, Q.¹ Bohin, N.² Wen, T.³ Ng, V.⁴ Magee, J.⁵ Chen, S.C.⁶ Shannon, K.⁷ Morrison, S.J.⁸

30
- 84899065964
- Clonal evolution and clinical correlates of somatic mutations in myeloproliferative neoplasms
- Lundberg, P., A. Karow, R. Nienhold, R. Looser, H. Hao-Shen, I. Nissen, S. Girsberger, T. Lehmann, J. Passweg, M. Stern, et al. 2014. Clonal evolution and clinical correlates of somatic mutations in myeloproliferative neoplasms. Blood. 123:2220-2228. http://dx.doi.org/10.1182/ blood-2013-11-537167
- (2014) Blood. , vol.123 , pp. 2220-2228
- Lundberg, P.¹ Karow, A.² Nienhold, R.³ Looser, R.⁴ Hao-Shen, H.⁵ Nissen, I.⁶ Girsberger, S.⁷ Lehmann, T.⁸ Passweg, J.⁹ Stern, M.¹⁰

31
- 67650632683
- CD47 is an adverse prognostic factor and therapeutic antibody target on human acute myeloid leukemia stem cells
- Majeti, R., M.P. Chao, A.A. Alizadeh, W.W. Pang, S. Jaiswal, K.D. Gibbs Jr., N. van Rooijen, and I.L. Weissman. 2009. CD47 is an adverse prognostic factor and therapeutic antibody target on human acute myeloid leukemia stem cells. Cell. 138:286-299. http://dx.doi.org/10.1016/j.cell.2009.05.045
- (2009) Cell. , vol.138 , pp. 286-299
- Majeti, R.¹ Chao, M.P.² Alizadeh, A.A.³ Pang, W.W.⁴ Jaiswal, S.⁵ Gibbs, K.D.⁶ van Rooijen, N.⁷ Weissman, I.L.⁸

32
- 77956280929
- Myeloproliferative neoplasm induced by constitutive expression of JAK2V617F in knock-in mice
- Marty, C., C. Lacout, A. Martin, S. Hasan, S. Jacquot, M.C. Birling, W. Vainchenker, and J.L. Villeval. 2010. Myeloproliferative neoplasm induced by constitutive expression of JAK2V617F in knock-in mice. Blood. 116:783-787. http://dx.doi.org/10.1182/blood-2009-12-257063
- (2010) Blood. , vol.116 , pp. 783-787
- Marty, C.¹ Lacout, C.² Martin, A.³ Hasan, S.⁴ Jacquot, S.⁵ Birling, M.C.⁶ Vainchenker, W.⁷ Villeval, J.L.⁸

33
- 0023245271
- Numbers and dispersion of repopulating hematopoietic cell clones in radiation chimeras as functions of injected cell dose
- Micklem, H.S., J.E. Lennon, J.D. Ansell, and R.A. Gray. 1987. Numbers and dispersion of repopulating hematopoietic cell clones in radiation chimeras as functions of injected cell dose. Exp. Hematol. 15:251-257.
- (1987) Exp. Hematol. , vol.15 , pp. 251-257
- Micklem, H.S.¹ Lennon, J.E.² Ansell, J.D.³ Gray, R.A.⁴

34
- 77953512588
- Heterogeneity and hierarchy within the most primitive hematopoietic stem cell compartment
- Morita, Y., H. Ema, and H. Nakauchi. 2010. Heterogeneity and hierarchy within the most primitive hematopoietic stem cell compartment. J. Exp. Med. 207:1173-1182. http://dx.doi.org/10.1084/jem.20091318
- (2010) J. Exp. Med. , vol.207 , pp. 1173-1182
- Morita, Y.¹ Ema, H.² Nakauchi, H.³

35
- 0028824811
- The purification and characterization of fetal liver hematopoietic stem cells
- Morrison, S.J., H.D. Hemmati, A.M. Wandycz, and I.L. Weissman. 1995. The purification and characterization of fetal liver hematopoietic stem cells. Proc. Natl. Acad. Sci. USA. 92:10302-10306. http://dx.doi.org/ 10.1073/pnas.92.22.10302
- (1995) Proc. Natl. Acad. Sci. USA. , vol.92 , pp. 10302-10306
- Morrison, S.J.¹ Hemmati, H.D.² Wandycz, A.M.³ Weissman, I.L.⁴

36
- 77953274727
- Physiological Jak2V617F expression causes a lethal myeloproliferative neoplasm with differential effects on hematopoietic stem and progenitor cells
- Mullally, A., S.W. Lane, B. Ball, C. Megerdichian, R. Okabe, F. Al-Shahrour, M. Paktinat, J.E. Haydu, E. Housman, A.M. Lord, et al. 2010. Physiological Jak2V617F expression causes a lethal myeloproliferative neoplasm with differential effects on hematopoietic stem and progenitor cells. Cancer Cell. 17:584-596. http://dx.doi.org/10.1016/j.ccr.2010.05.015
- (2010) Cancer Cell. , vol.17 , pp. 584-596
- Mullally, A.¹ Lane, S.W.² Ball, B.³ Megerdichian, C.⁴ Okabe, R.⁵ Al-Shahrour, F.⁶ Paktinat, M.⁷ Haydu, J.E.⁸ Housman, E.⁹ Lord, A.M.¹⁰

37
- 84863589906
- Distinct roles for long-term hematopoietic stem cells and erythroid precursor cells in a murine model of Jak2V617F-mediated polycythemia vera
- Mullally, A., L. Poveromo, R.K. Schneider, F. Al-Shahrour, S.W. Lane, and B.L. Ebert. 2012. Distinct roles for long-term hematopoietic stem cells and erythroid precursor cells in a murine model of Jak2V617F-mediated polycythemia vera. Blood. 120:166-172. http://dx.doi.org/10.1182/ blood-2012-01-402396
- (2012) Blood. , vol.120 , pp. 166-172
- Mullally, A.¹ Poveromo, L.² Schneider, R.K.³ Al-Shahrour, F.⁴ Lane, S.W.⁵ Ebert, B.L.⁶

38
- 84879728130
- Depletion of Jak2V617F myeloproliferative neoplasm-propagating stem cells by interferon-α in a murine model of polycythemia vera
- Mullally, A., C. Bruedigam, L. Poveromo, F.H. Heidel, A. Purdon, T. Vu, R. Austin, D. Heckl, L.J. Breyfogle, C.P. Kuhn, et al. 2013. Depletion of Jak2V617F myeloproliferative neoplasm-propagating stem cells by interferon-α in a murine model of polycythemia vera. Blood. 121:3692- 3702. http://dx.doi.org/10.1182/blood-2012-05-432989
- (2013) Blood. , vol.121 , pp. 3692- 3702
- Mullally, A.¹ Bruedigam, C.² Poveromo, L.³ Heidel, F.H.⁴ Purdon, A.⁵ Vu, T.⁶ Austin, R.⁷ Heckl, D.⁸ Breyfogle, L.J.⁹ Kuhn, C.P.¹⁰

39
- 84890328032
- Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2
- Nangalia, J., C.E. Massie, E.J. Baxter, F.L. Nice, G. Gundem, D.C. Wedge, E. Avezov, J. Li, K. Kollmann, D.G. Kent, et al. 2013. Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2. N. Engl. J. Med. 369:2391-2405. http://dx.doi.org/10.1056/NEJMoa1312542
- (2013) N. Engl. J. Med. , vol.369 , pp. 2391-2405
- Nangalia, J.¹ Massie, C.E.² Baxter, E.J.³ Nice, F.L.⁴ Gundem, G.⁵ Wedge, D.C.⁶ Avezov, E.⁷ Li, J.⁸ Kollmann, K.⁹ Kent, D.G.¹⁰

40
- 79952326353
- The JAK2 V617F somatic mutation, mortality and cancer risk in the general population
- Nielsen, C., H.S. Birgens, B.G. Nordestgaard, L. Kjaer, and S.E. Bojesen. 2011. The JAK2 V617F somatic mutation, mortality and cancer risk in the general population. Haematologica. 96:450-453. http://dx.doi.org/10.3324/ haematol.2010.033191
- (2011) Haematologica. , vol.96 , pp. 450-453
- Nielsen, C.¹ Birgens, H.S.² Nordestgaard, B.G.³ Kjaer, L.⁴ Bojesen, S.E.⁵

41
- 77953485892
- Novel mutations in the inhibitory adaptor protein LNK drive JAK-STAT signaling in patients with myeloproliferative neoplasms
- Oh, S.T., E.F. Simonds, C. Jones, M.B. Hale, Y. Goltsev, K.D. Gibbs Jr., J.D. Merker, J.L. Zehnder, G.P. Nolan, and J. Gotlib. 2010. Novel mutations in the inhibitory adaptor protein LNK drive JAK-STAT signaling in patients with myeloproliferative neoplasms. Blood. 116:988-992. http:// dx.doi.org/10.1182/blood-2010-02-270108
- (2010) Blood. , vol.116 , pp. 988-992
- Oh, S.T.¹ Simonds, E.F.² Jones, C.³ Hale, M.B.⁴ Goltsev, Y.⁵ Gibbs, K.D.⁶ Merker, J.D.⁷ Zehnder, J.L.⁸ Nolan, G.P.⁹ Gotlib, J.¹⁰

42
- 63449134208
- A common JAK2 haplotype confers susceptibility to myeloproliferative neoplasms
- Olcaydu, D., A. Harutyunyan, R. Jäger, T. Berg, B. Gisslinger, I. Pabinger, H. Gisslinger, and R. Kralovics. 2009. A common JAK2 haplotype confers susceptibility to myeloproliferative neoplasms. Nat. Genet. 41:450- 454. http://dx.doi.org/10.1038/ng.341
- (2009) Nat. Genet. , vol.41 , pp. 450- 454
- Olcaydu, D.¹ Harutyunyan, A.² Jäger, R.³ Berg, T.⁴ Gisslinger, B.⁵ Pabinger, I.⁶ Gisslinger, H.⁷ Kralovics, R.⁸

43
- 33746437130
- MPLW515L is a novel somatic activating mutation in myelofibrosis with myeloid metaplasia
- Pikman, Y., B.H. Lee, T. Mercher, E. McDowell, B.L. Ebert, M. Gozo, A. Cuker, G. Wernig, S. Moore, I. Galinsky, et al. 2006. MPLW515L is a novel somatic activating mutation in myelofibrosis with myeloid metaplasia. PLoS Med. 3:e270. http://dx.doi.org/10.1371/journal.pmed.0030270
- (2006) PLoS Med. , vol.3 , pp. e270
- Pikman, Y.¹ Lee, B.H.² Mercher, T.³ McDowell, E.⁴ Ebert, B.L.⁵ Gozo, M.⁶ Cuker, A.⁷ Wernig, G.⁸ Moore, S.⁹ Galinsky, I.¹⁰

44
- 51649087754
- JAK2 stimulates homologous recombination and genetic instability: potential implication in the heterogeneity of myeloproliferative disorders
- Plo, I., M. Nakatake, L. Malivert, J.P. de Villartay, S. Giraudier, J.L. Villeval, L. Wiesmuller, and W. Vainchenker. 2008. JAK2 stimulates homologous recombination and genetic instability: potential implication in the heterogeneity of myeloproliferative disorders. Blood. 112:1402-1412. http://dx.doi.org/10.1182/blood-2008-01-134114
- (2008) Blood. , vol.112 , pp. 1402-1412
- Plo, I.¹ Nakatake, M.² Malivert, L.³ de Villartay, J.P.⁴ Giraudier, S.⁵ Villeval, J.L.⁶ Wiesmuller, L.⁷ Vainchenker, W.⁸

45
- 0030927503
- Phenotypic and functional changes induced at the clonal level in hematopoietic stem cells after 5-fluorouracil treatment
- Randall, T.D., and I.L. Weissman. 1997. Phenotypic and functional changes induced at the clonal level in hematopoietic stem cells after 5-fluorouracil treatment. Blood. 89:3596-3606.
- (1997) Blood. , vol.89 , pp. 3596-3606
- Randall, T.D.¹ Weissman, I.L.²

46
- 68949124841
- Gain-offunction of mutated C-CBL tumour suppressor in myeloid neoplasms
- Sanada, M., T. Suzuki, L.Y. Shih, M. Otsu, M. Kato, S. Yamazaki, A. Tamura, H. Honda, M. Sakata-Yanagimoto, K. Kumano, et al. 2009. Gain-offunction of mutated C-CBL tumour suppressor in myeloid neoplasms. Nature. 460:904-908. http://dx.doi.org/10.1038/nature08240
- (2009) Nature. , vol.460 , pp. 904-908
- Sanada, M.¹ Suzuki, T.² Shih, L.Y.³ Otsu, M.⁴ Kato, M.⁵ Yamazaki, S.⁶ Tamura, A.⁷ Honda, H.⁸ Sakata-Yanagimoto, M.⁹ Kumano, K.¹⁰

47
- 84885634008
- Plateletbiased stem cells reside at the apex of the haematopoietic stem-cell hierarchy
- Sanjuan-Pla, A., I.C. Macaulay, C.T. Jensen, P.S. Woll, T.C. Luis, A. Mead, S. Moore, C. Carella, S. Matsuoka, T. Bouriez Jones, et al. 2013. Plateletbiased stem cells reside at the apex of the haematopoietic stem-cell hierarchy. Nature. 502:232-236. http://dx.doi.org/10.1038/nature12495
- (2013) Nature. , vol.502 , pp. 232-236
- Sanjuan-Pla, A.¹ Macaulay, I.C.² Jensen, C.T.³ Woll, P.S.⁴ Luis, T.C.⁵ Mead, A.⁶ Moore, S.⁷ Carella, C.⁸ Matsuoka, S.⁹ Bouriez Jones, T.¹⁰

48
- 0035894949
- Observation of antigen-dependent CD8+ T-cell/dendritic cell interactions in vivo
- Schaefer, B.C., M.L. Schaefer, J.W. Kappler, P. Marrack, and R.M. Kedl. 2001. Observation of antigen-dependent CD8+ T-cell/dendritic cell interactions in vivo. Cell. Immunol. 214:110-122. http://dx.doi.org/10.1006/ cimm.2001.1895
- (2001) Cell. Immunol. , vol.214 , pp. 110-122
- Schaefer, B.C.¹ Schaefer, M.L.² Kappler, J.W.³ Marrack, P.⁴ Kedl, R.M.⁵

49
- 61849118935
- Clonal analysis of deletions on chromosome 20q and JAK2-V617F in MPD suggests that del20q acts independently and is not one of the predisposing mutations for JAK2-V617F
- Schaub, F.X., R. Jäger, R. Looser, H. Hao-Shen, S. Hermouet, F. Girodon, A. Tichelli, H. Gisslinger, R. Kralovics, and R.C. Skoda. 2009. Clonal analysis of deletions on chromosome 20q and JAK2-V617F in MPD suggests that del20q acts independently and is not one of the predisposing mutations for JAK2-V617F. Blood. 113:2022-2027. http://dx.doi.org/10 .1182/blood-2008-07-167056
- (2009) Blood. , vol.113 , pp. 2022-2027
- Schaub, F.X.¹ Jäger, R.² Looser, R.³ Hao-Shen, H.⁴ Hermouet, S.⁵ Girodon, F.⁶ Tichelli, A.⁷ Gisslinger, H.⁸ Kralovics, R.⁹ Skoda, R.C.¹⁰

50
- 77950388949
- Clonal analysis of TET2 and JAK2 mutations suggests that TET2 can be a late event in the progression of myeloproliferative neoplasms
- Schaub, F.X., R. Looser, S. Li, H. Hao-Shen, T. Lehmann, A. Tichelli, and R.C. Skoda. 2010. Clonal analysis of TET2 and JAK2 mutations suggests that TET2 can be a late event in the progression of myeloproliferative neoplasms. Blood. 115:2003-2007. http://dx.doi.org/10.1182/blood-2009- 09-245381
- (2010) Blood. , vol.115 , pp. 2003-2007
- Schaub, F.X.¹ Looser, R.² Li, S.³ Hao-Shen, H.⁴ Lehmann, T.⁵ Tichelli, A.⁶ Skoda, R.C.⁷

51
- 77951446379
- BCRABL enhances differentiation of long-term repopulating hematopoietic stem cells
- Schemionek, M., C. Elling, U. Steidl, N. Bäumer, A. Hamilton, T. Spieker, J.R. Göthert, M. Stehling, A. Wagers, C.S. Huettner, et al. 2010. BCRABL enhances differentiation of long-term repopulating hematopoietic stem cells. Blood. 115:3185-3195. http://dx.doi.org/10.1182/blood- 2009-04-215376
- (2010) Blood. , vol.115 , pp. 3185-3195
- Schemionek, M.¹ Elling, C.² Steidl, U.³ Bäumer, N.⁴ Hamilton, A.⁵ Spieker, T.⁶ Göthert, J.R.⁷ Stehling, M.⁸ Wagers, A.⁹ Huettner, C.S.¹⁰

52
- 33749358349
- Progenitors homozygous for the V617F mutation occur in most patients with polycythemia vera, but not essential thrombocythemia
- Scott, L.M., M.A. Scott, P.J. Campbell, and A.R. Green. 2006. Progenitors homozygous for the V617F mutation occur in most patients with polycythemia vera, but not essential thrombocythemia. Blood. 108:2435-2437. http://dx.doi.org/10.1182/blood-2006-04-018259
- (2006) Blood. , vol.108 , pp. 2435-2437
- Scott, L.M.¹ Scott, M.A.² Campbell, P.J.³ Green, A.R.⁴

53
- 33747599596
- The JAK2V617F mutation is detectable at very low level in peripheral blood of healthy donors
- Sidon, P., H. El Housni, B. Dessars, and P. Heimann. 2006. The JAK2V617F mutation is detectable at very low level in peripheral blood of healthy donors. Leukemia. 20:1622. http://dx.doi.org/10.1038/sj.leu.2404292
- (2006) Leukemia. , vol.20 , pp. 1622
- Sidon, P.¹ El Housni, H.² Dessars, B.³ Heimann, P.⁴

54
- 33644781621
- The hematopoietic stem compartment consists of a limited number of discrete stem cell subsets
- Sieburg, H.B., R.H. Cho, B. Dykstra, N. Uchida, C.J. Eaves, and C.E. Muller- Sieburg. 2006. The hematopoietic stem compartment consists of a limited number of discrete stem cell subsets. Blood. 107:2311-2316. http://dx .doi.org/10.1182/blood-2005-07-2970
- (2006) Blood. , vol.107 , pp. 2311-2316
- Sieburg, H.B.¹ Cho, R.H.² Dykstra, B.³ Uchida, N.⁴ Eaves, C.J.⁵ Muller-Sieburg, C.E.⁶

55
- 0023922373
- Purification and characterization of mouse hematopoietic stem cells
- Spangrude, G.J., S. Heimfeld, and I.L. Weissman. 1988. Purification and characterization of mouse hematopoietic stem cells. Science. 241:58-62. http://dx.doi.org/10.1126/science.2898810
- (1988) Science. , vol.241 , pp. 58-62
- Spangrude, G.J.¹ Heimfeld, S.² Weissman, I.L.³

56
- 84873848473
- Lysosomal disruption preferentially targets acute myeloid leukemia cells and progenitors
- Sukhai, M.A., S. Prabha, R. Hurren, A.C. Rutledge, A.Y. Lee, S. Sriskanthadevan, H. Sun, X. Wang, M. Skrtic, A. Seneviratne, et al. 2013. Lysosomal disruption preferentially targets acute myeloid leukemia cells and progenitors. J. Clin. Invest. 123:315-328. http://dx.doi.org/10.1172/JCI64180
- (2013) J. Clin. Invest. , vol.123 , pp. 315-328
- Sukhai, M.A.¹ Prabha, S.² Hurren, R.³ Rutledge, A.C.⁴ Lee, A.Y.⁵ Sriskanthadevan, S.⁶ Sun, H.⁷ Wang, X.⁸ Skrtic, M.⁹ Seneviratne, A.¹⁰

57
- 79951698622
- Dynamic variation in cycling of hematopoietic stem cells in steady state and inflammation
- Takizawa, H., R.R. Regoes, C.S. Boddupalli, S. Bonhoeffer, and M.G. Manz. 2011. Dynamic variation in cycling of hematopoietic stem cells in steady state and inflammation. J. Exp. Med. 208:273-284. http://dx.doi .org/10.1084/jem.20101643
- (2011) J. Exp. Med. , vol.208 , pp. 273-284
- Takizawa, H.¹ Regoes, R.R.² Boddupalli, C.S.³ Bonhoeffer, S.⁴ Manz, M.G.⁵

58
- 43249084493
- Ratio of mutant JAK2-V617F to wild-type Jak2 determines the MPD phenotypes in transgenic mice
- Tiedt, R., H. Hao-Shen, M.A. Sobas, R. Looser, S. Dirnhofer, J. Schwaller, and R.C. Skoda. 2008. Ratio of mutant JAK2-V617F to wild-type Jak2 determines the MPD phenotypes in transgenic mice. Blood. 111:3931- 3940. http://dx.doi.org/10.1182/blood-2007-08-107748
- (2008) Blood. , vol.111 , pp. 3931- 3940
- Tiedt, R.¹ Hao-Shen, H.² Sobas, M.A.³ Looser, R.⁴ Dirnhofer, S.⁵ Schwaller, J.⁶ Skoda, R.C.⁷

59
- 55449105991
- Maximal STAT5- induced proliferation and self-renewal at intermediate STAT5 activity levels
- Wierenga, A.T.J., E. Vellenga, and J.J. Schuringa. 2008. Maximal STAT5- induced proliferation and self-renewal at intermediate STAT5 activity levels. Mol. Cell. Biol. 28:6668-6680. http://dx.doi.org/10.1128/ MCB.01025-08
- (2008) Mol. Cell. Biol. , vol.28 , pp. 6668-6680
- Wierenga, A.T.J.¹ Vellenga, E.² Schuringa, J.J.³

60
- 0034144665
- Expression of CD27 on murine hematopoietic stem and progenitor cells
- Wiesmann, A., R.L. Phillips, M. Mojica, L.J. Pierce, A.E. Searles, G.J. Spangrude, and I. Lemischka. 2000. Expression of CD27 on murine hematopoietic stem and progenitor cells. Immunity. 12:193-199. http:// dx.doi.org/10.1016/S1074-7613(00)80172-7
- (2000) Immunity. , vol.12 , pp. 193-199
- Wiesmann, A.¹ Phillips, R.L.² Mojica, M.³ Pierce, L.J.⁴ Searles, A.E.⁵ Spangrude, G.J.⁶ Lemischka, I.⁷

61
- 35948964020
- Meis1 is an essential and rate-limiting regulator of MLL leukemia stem cell potential
- Wong, P., M. Iwasaki, T.C. Somervaille, C.W. So, and M.L. Cleary. 2007. Meis1 is an essential and rate-limiting regulator of MLL leukemia stem cell potential. Genes Dev. 21:2762-2774. http://dx.doi.org/10.1101/ gad.1602107
- (2007) Genes Dev. , vol.21 , pp. 2762-2774
- Wong, P.¹ Iwasaki, M.² Somervaille, T.C.³ So, C.W.⁴ Cleary, M.L.⁵

62
- 33846012829
- JAK2(V617F): Prevalence in a large Chinese hospital population
- Xu, X., Q. Zhang, J. Luo, S. Xing, Q. Li, S.B. Krantz, X. Fu, and Z.J. Zhao. 2007. JAK2(V617F): Prevalence in a large Chinese hospital population. Blood. 109:339-342. http://dx.doi.org/10.1182/blood-2006-03-009472
- (2007) Blood. , vol.109 , pp. 339-342
- Xu, X.¹ Zhang, Q.² Luo, J.³ Xing, S.⁴ Li, Q.⁵ Krantz, S.B.⁶ Fu, X.⁷ Zhao, Z.J.⁸

63
- 84883428326
- Clonal analysis unveils self-renewing lineage-restricted progenitors generated directly from hematopoietic stem cells
- Yamamoto, R., Y. Morita, J. Ooehara, S. Hamanaka, M. Onodera, K.L. Rudolph, H. Ema, and H. Nakauchi. 2013. Clonal analysis unveils self-renewing lineage-restricted progenitors generated directly from hematopoietic stem cells. Cell. 154:1112-1126. http://dx.doi.org/10 .1016/j.cell.2013.08.007
- (2013) Cell. , vol.154 , pp. 1112-1126
- Yamamoto, R.¹ Morita, Y.² Ooehara, J.³ Hamanaka, S.⁴ Onodera, M.⁵ Rudolph, K.L.⁶ Ema, H.⁷ Nakauchi, H.⁸

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.